Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Lozanoska-Ochser: Atorvastatin Fails to Prevent the Development of Autoimmune Diabetes Despite.... (0.16 sec) 

Atorvastatin Fails to Prevent the Development of Autoimmune Diabetes Despite Inhibition of …

- diabetesjournals.org
B Lozanoska-Ochser, F Barone, C Pitzalis, … - Diabetes, 2006 - Am Diabetes Assoc
Statins, the widely used inhibitors of cholesterol biosynthesis, also have
immunomodulatory properties. Statins have recently been shown to have beneficial
prophylactic and therapeutic effects in actively induced, short-term animal ...
Cited by 13 - Related articles - BL Direct - All 4 versions

Atorvastatin Fails to Prevent the Development of Autoimmune Diabetes Despite Inhibition …


B Lozanoska-Ochser, F Barone, C Pitzalis, … - 糖尿病学杂志, 2006 - journal.shouxi.net
Statins, the widely used inhibitors of cholesterol biosynthesis, also have
immunomodulatory properties. Statins have recently been shown to have beneficial
prophylactic and therapeutic effects in actively induced, short-term animal ...
Related articles - Cached

Atorvastatin does not decrease or delay diabetes onset in two different mouse models of …


X Palomer, L Calpe-Berdiel, J Verdaguer, J … - Diabetologia, 2005 - Springer
Page 1. Diabetologia (2005) 48: 1671–1673 DOI 10.1007/s00125-005-1834-z RESEARCH
LETTER X. Palomer . L. Calpe-Berdiel . J. Verdaguer . J. Carrillo . ...
Cited by 4 - Related articles - BL Direct - All 3 versions

Use of high-sensitivity CRP to predict first cardiovascular events

- clinpharm.de [PDF] 
HD Stahl - The Lancet, 2007 - Elsevier
The JUPITER trial 1 is a randomised comparison of rosuvastatin with placebo in
15 000 patients (men aged 55 years or older and women aged 65 years or older)
who have normal LDL cholesterol concentrations and mildly raised high- ...
Cited by 3 - Related articles - All 13 versions

The effects of atorvastatin in experimental autoimmune uveitis

- nih.gov - Free from Publisher
PB Thomas, T Albini, RK Giri, RF See, M … - British Journal of Ophthalmology, 2005 - bjo.bmj.com
Methods: 48 B10-RIII mice were immunised with human interphotoreceptor retinoid
binding protein (IRBP) peptide p161–180. They were divided into three groups
of 16 each and treated orally once daily for 14 days; group one received ...
Cited by 12 - Related articles - All 9 versions

Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the …


XJ Xu, C Gearon, E Stevens, D Vergani, H … - Diabetologia, 1999 - Springer
In autoimmune diseases such as Type I (insulin-de- pendent) diabetes mellitus in
man and spontaneous diabetes in the non-obese diabetic (NOD) mouse, the ...
Spontaneous T-cell proliferation in the non-obese diabetic mouse
Cited by 12 - Related articles - BL Direct - All 4 versions

Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse.

- nih.gov [PDF] 
RA Smerdon, M Peakman, MJ Hussain, D … - Immunology, 1993 - pubmedcentral.nih.gov
SUMMARY The aim of this study was to investigate whether lymphocyte vaccination
can prevent diabetes occurring in the non-obese diabetic (NOD) mouse, an animal
model of human insulin-dependent diabetes mellitus (IDDM). The lymphocyte ...
Cited by 16 - Related articles - BL Direct - All 3 versions

Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in …

- aspetjournals.org
T Rydgren, O Vaarala, S Sandler - Journal of Pharmacology and Experimental …, 2007 - ASPET
Statins are drugs well known for their cholesterol-lowering properties. Lately,
statins have been shown to possess anti-inflammatory properties that might be
attributed to inhibition of leukocyte adhesion and migration to sites of ...
Cited by 6 - Related articles - All 4 versions

On the association between statin and fracture: A Bayesian consideration

- osvn.info [PDF] 
ND Nguyen, CY Wang, JA Eisman, TV … - Bone, 2007 - Elsevier
Empirical Bayesian analysis showed that statin use was associated with a
reduction in hip fracture risk (OR = 0.57, 95% credible interval (CrI):
0.46–0.71) and for non-vertebral (OR = 0.69, 95% CrI, 0.63–0.74). These ...
Cited by 6 - Related articles - All 27 versions

T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives

- bentham.org [PDF] 
R Ghittoni, E Lazzerini, L Pasini, CT Baldari - Inflammation &# 38; Allergy-Drug Targets (Formerly …, 2007 - ingentaconnect.com
Abstract: Statins are cholesterol-lowering drugs extensively used for primary
and secondary prevention of cardiovascular events related to
hypercholesterolemia. Because of their capacity to inhibit HMG-CoA ...
Cited by 6 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google